Danone Offers to Buy Lifeway Foods for $283.4 Million
By Connor Hart
Danone has offered to buy the shares of Lifeway Foods that it doesn't already own for about $283.4 million.
The acquisition would be wholly funded in cash from existing reserves and is not contingent on any financing requirements, according to a Securities and Exchange Commission filing Monday.
Danone, a Paris-based food and beverage company, already owns about 3.45 million shares of Lifeway, representing about 23% of the Illinois-based food manufacturer's 14.8 million outstanding shares as of Aug. 6. It offered to buy all outstanding shares of Lifeway that it did not already own for $25 each.
The company said it intends to engage in discussions with Lifeway regarding the proposed acquisition. Danone warned that terms of the acquisition proposal could change, as there is no guarantee a deal will take place and no legally-binding obligation between the companies ahead of entering mutually-acceptable definitive documentation.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
September 23, 2024 17:06 ET (21:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks